Progeny Genetics Names New Chief Executive Officer – Yahoo Finance

DELRAY BEACH, Fla.--(BUSINESS WIRE)--

Progeny Genetics LLC (Progeny), a leading risk modeling pedigree software for clinicians, announced today that Jamie LHeureux, MS, CGC has been appointed to the role of Chief Executive Officer. For 20 years, Progeny has assisted healthcare providers with patient screening, risk analysis, order processing, clinical review, and letter generation.

Ms. LHeureux brings over 12 years of experience in both research and clinical genetics as a Board Certified genetic counselor. She received her Masters degree in Medical Genetics from the University of Cincinnatis Genetic Counseling Training Program and began her career at the University of Iowa as a Research Coordinator for several international research projects.

Ms. LHeureuxs strong background in software development includes implementing new laboratory information management systems and designing patient-facing Family History Questionnaires. For the past three years, Ms. LHeureux served as Software Product Manager at Progeny, and was integral to development of Progenys letter generation feature and integrated risk models.

I am excited to be able to use my past experience as a Progeny user, both in the research and clinical genetic counseling settings, to help build upon the strong foundation that Progeny already has established, and make it even more user-friendly for our healthcare provider customers and their patients, said Ms. LHeureux. We have some exciting improvements coming up that are focused on saving clinicians time and simplifying their workflow.

As a prominent member of the Progeny leadership team, Ms. LHeureux helps guide the future of the company by leveraging her extensive experience as a genetic counselor. In addition, her software development knowledge provides a solid foundation for Ms. LHeureux to harness the needs of Progenys healthcare provider clientele.

Progenys software is available in over 2,400 unique sites in 80 countries worldwide. Progeny has played a prominent role in advancing science by bringing family history to the forefront of genetic healthcare, with the intention that the information provided to healthcare providers will assist them with early detection and intervention to patients with genetic predispositions.

Progeny became a subsidiary of Ambry Genetics (Ambry), a genetic testing company based in Aliso Viejo, California, in April 2015. Progenys software helps healthcare providers analyze hereditary family history data so clinicians can effectively identify genetic risk factors in patients and their families.

For more information about Progenys services and support, visit here.

ABOUT PROGENY GENETICS:

Progeny is a subsidiary of Ambry Genetics, providing customizable family history, pedigree, sample, and genetic data management software solutions to healthcare providers worldwide. Using Progenys sophisticated technology, healthcare providers can collect family history from patients, review and edit pedigrees, run integrated risk models, order and review genetic testing, and integrate into the electronic medical record, allowing healthcare providers to embrace personalized healthcare like never before. For more information about Progeny, visit http://www.progenygenetics.com.

ABOUT AMBRY GENETICS

Ambry Genetics is both College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified. Ambry leads in clinical genetic diagnostics and genetics software solutions, combining both to offer the most comprehensive testing menu in the industry. Ambry has established a reputation for sharing data while safeguarding patient privacy, unparalleled service, and responsibly applying new technologies to the clinical molecular diagnostics market. For more information about Ambry Genetics, visit http://www.ambrygen.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170426005282/en/

Go here to read the rest:
Progeny Genetics Names New Chief Executive Officer - Yahoo Finance

Related Posts